Appendix cancer natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 15: Line 15:
Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.


 
???????Tumor size plays a crucial role in determining prognosis,Most of appendiceal tumors are less than 2 cm in size and have a quite favorable prognosis since they barely metastasize. The 5-year survival rate for adenocarcinoma of appendix is approximately 71% (see the Table below). ((Modin sanda)))????????
""""""??????Appendiceal Carcinoid Tumors
Thought to arise from the subepithelial endocrine cells in the lamina propria and submucosa, appendiceal carcinoid tumors are the most common neoplasms affecting the appendix [54–55]. They are most often discovered during the fourth or fifth decade of life as an incidental finding during surgery performed for other reasons. Most patients with appendiceal carcinoids are asymptomatic, likely due to the location of the neoplasm in relation to the appendiceal base; the vast majority (75%) are located in the distal third of the appendix, where the risk of obstruction is low, with the remainder located in the middle third, and less than 10% at the base [11]. In a series of 150 appendiceal carcinoids, Moertel et al demonstrated that most appendiceal neoplasms were less than 1cm in largest dimension, though larger tumors (>2cm) appeared to be associated with poorer prognosis and increased patient discomfort [56]. In fact, more than 50% of patients who had large appendiceal carcinoids in one study presented with a clinical picture suggestive of acute appendicitis [57]. The prognosis for tumors less than 2 cm in size is quite favorable, as few of these neoplasms metastasize. The 5-year survival rate overall is approximately 71% (94% for local disease, 85% for regional metastases, and 34% in the presence of distal disease) [7, 53].??????""""""


==Natural History, Complications, and Prognosis==
==Natural History, Complications, and Prognosis==

Revision as of 21:03, 16 January 2019

Appendix cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology and Demographics

Differentiating Appendix cancer from other Diseases

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

MRI

CT scan

Echocardiography and Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Appendix cancer natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Appendix cancer natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Appendix cancer natural history, complications and prognosis

CDC on Appendix cancer natural history, complications and prognosis

Appendix cancer natural history, complications and prognosis in the news

Blogs on Appendix cancer natural history, complications and prognosis

Directions to Hospitals Treating Appendix cancer

Risk calculators and risk factors for Appendix cancer natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2]

Overview

If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].

OR

Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].

OR

Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.

???????Tumor size plays a crucial role in determining prognosis,Most of appendiceal tumors are less than 2 cm in size and have a quite favorable prognosis since they barely metastasize. The 5-year survival rate for adenocarcinoma of appendix is approximately 71% (see the Table below). ((Modin sanda)))????????

Natural History, Complications, and Prognosis

Natural History

  • The symptoms of (disease name) usually develop in the first/ second/ third decade of life, and start with symptoms such as ___.
  • The symptoms of (disease name) typically develop ___ years after exposure to ___.
  • If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].

Complications

  • Common complications of appendix cancer include:
    • Acute appendicitis
    • Pseudomyxoma pritonei
    • ?????????

Prognosis

  • Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [--]%.
  • Depending on the extent of the [tumor/disease progression] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
  • The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
  • [Subtype of disease/malignancy] is associated with the most favorable prognosis.
  • The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.
Five year survival rates
Carcinoid tumors
  • localized disease 94%
  • Regional disease 85%
  • Distant metastases 34%
  • Goblet cell 12.5%
  • Tubular tumors are benign clinically
Adenocarcinoma
Nonmucinus
  • Localized 95%
  • Distant metastasis 0%*
Mucinous adenocarcinoma
  • localized 80%
  • Distant metastasis 51%*
* Shows that mucinous adenocarcinoma are less aggressive than nunmnucinous tumors
  • Poor prognostic factors for appendiceal adenocarcinoma are as follows:
    • Advanced stage
    • High grade
    • Nonmucinous histology
    • Spread of the tumor beyond the left lower quadrant
    • Presence of malignant cells outside of the visceral peritoneum of the appendix
  • Poor prognostic factors in the presence of pseudomyxoma peritonei are as follows:
    • Abdominal distension
    • Weight loss
    • High histological grade
    • Morphological evidence of invasion of underlying structures


??????????

  • Genetic studies revolutionized cancer treatment, appendix cancer is not an exception.
  • Traditionally appandiceal cancers were approached the same as colorectal cancers.
  • Recent genetic studies demonstrated that appendiceal tumors are clearly differ from colorectal cancers.[1]
  • Presence of mutated TP53 and APC genes were significantly lower in appendiceal cancers compared to colorectal cancers.
  • It has been shown that mutation profiles are associated with the patients’ prognosis. [2]
  • Mutations in the TP53 significantly decrease life expectancy in patients with appendix cancer.
  • Regardless of tumor grade, Tp 53 mutations were associated with poorer outcomes.
  • Patients with GNAS mutations had a life expectancy of 10 years after diagnosis.
  • Appendiceal tumors with GNAS mutations rarely develop into high-grade tumors.

References

  1. Levine EA, Blazer DG, Kim MK, Shen P, Stewart JH, Guy C; et al. (2012). "Gene expression profiling of peritoneal metastases from appendiceal and colon cancer demonstrates unique biologic signatures and predicts patient outcomes". J Am Coll Surg. 214 (4): 599–606, discussion 606-7. doi:10.1016/j.jamcollsurg.2011.12.028. PMC 3768122. PMID 22342786.
  2. Levine EA, Votanopoulos KI, Qasem SA, Philip J, Cummins KA, Chou JW; et al. (2016). "Prognostic Molecular Subtypes of Low-Grade Cancer of the Appendix". J Am Coll Surg. 222 (4): 493–503. doi:10.1016/j.jamcollsurg.2015.12.012. PMC 4808611. PMID 26821970.

Template:WH Template:WS